Form 4: H.B. Fuller Co. Executive Heather Campe Reports Stock and Derivative Transactions
SEC Form 4 Filing
Heather Campe, Sr. VP of International Growth at H.B. Fuller Co., reports acquisition of phantom units and adjustments to stock and option holdings.
Summary
- Heather Campe, a Senior VP at H.B. Fuller Co., filed a Form 4 detailing changes in her beneficial ownership of company stock and derivatives.
- On September 13, 2024, Campe acquired 26.06 phantom units that convert into common stock.
- She directly owns 19,741.79 shares of common stock, which includes shares acquired through a dividend reinvestment plan.
- Campe also holds multiple employee stock options with various exercise prices and expiration dates, as well as restricted stock units that vest annually.
- The reported transactions include acquisitions of phantom units and adjustments to existing holdings of stock options and restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions.
Positives
- The reporting person's continued holding of company stock and options suggests confidence in the company's future performance.
- Dividend reinvestment indicates a long-term investment strategy.
Future Outlook
The document does not contain any explicit forward-looking statements regarding the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, common for publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders, similar to practices at companies like 3M and Ecolab.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
- It assures stakeholders that executives' interests are aligned with theirs through equity ownership.
Key Dates
| Date | Description |
|---|---|
| 01/25/2019 | Date of employee stock option grant with exercise price $53.57, expiring 01/25/2028. |
| 01/27/2022 | Date of employee stock option grant with exercise price $51.89, expiring 01/27/2031. |
| 01/24/2023 | First vesting date for restricted stock units granted 01/24/2023, expiring 01/24/2025. |
| 01/24/2023 | Date of employee stock option grant with exercise price $72.94, expiring 01/24/2032. |
| 01/24/2024 | First vesting date for restricted stock units granted 01/24/2024, expiring 01/24/2026. |
| 01/24/2024 | Date of employee stock option grant with exercise price $68.17, expiring 01/24/2033. |
| 01/26/2025 | First vesting date for restricted stock units granted 01/26/2025, expiring 01/26/2027. |
| 01/26/2025 | Date of employee stock option grant with exercise price $77.72, expiring 01/26/2034. |
| 09/13/2024 | Date of transaction: acquisition of phantom units. |
| 09/16/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.